Activin A Causes Muscle Atrophy through MEF2C-Dependent Impaired Myogenesis.
Ontology highlight
ABSTRACT: Activin A (ActA) is considered to play a major role in cancer-induced cachexia (CC). Indeed, circulating ActA levels are elevated and predict survival in patients with CC. However, the mechanisms by which ActA mediates CC development and in particular skeletal muscle (SM) atrophy in humans are not yet fully understood. In this work, we aimed to investigate the effects of ActA on human SM and in mouse models of CC. We used a model of human muscle cells in culture to explore how ActA acts towards human SM. In this model, recombinant ActA induced myotube atrophy associated with the decline of MyHC-β/slow, the main myosin isoform in human muscle cells studied. Moreover, ActA inhibited the expression and activity of MEF2C, the transcription factor regulating MYH7, the gene which codes fo
SUBMITTER: Loumaye A
PROVIDER: S-EPMC8997966 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA